Azitra (AZTR) Current Assets (2022 - 2026)
Azitra's (AZTR) quarterly Current Assets came in at $10.8 million in Q1 2026, up 177.93% YoY from $3.9 million in Q1 2025, and up 256.38% on a QoQ basis from $3.0 million in Q4 2025.
Azitra (AZTR) Current Assets (2022 - 2026) Analysis & Trends
Azitra (AZTR) has 5 years of Current Assets data on file, last reported at $10.8 million in Q1 2026.
- Quarterly Current Assets rose 177.93% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.8 million (up 177.93% YoY) and the FY2025 annual result came in at $3.0 million, down 42.25% from the prior year.
- Current Assets advanced to $10.8 million in Q1 2026, from $3.0 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $10.8 million in Q1 2026 to a low of $1.3 million in Q2 2024.
- A 5-year average of $4.4 million and a median of $3.9 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets plunged 80.47% — and 2026, when it jumped 177.93%.
- Tracing AZTR's Current Assets over 5 years: stood at $4.1 million in 2022, then plunged by 38.69% to $2.5 million in 2023, then soared by 106.2% to $5.2 million in 2024, then tumbled by 42.25% to $3.0 million in 2025, then surged by 256.38% to $10.8 million in 2026.
- The last three Current Assets figures came in at $10.8 million (Q1 2026), $3.0 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - | 1.76 Bn |
| 10 | Azitra | 2.58 Mn | 2.58 Mn | - | 7.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.44 Mn |
| Mar 31, 2026 | 10.76 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Dec 31, 2024 | 5.23 Mn |
| Sep 30, 2024 | 7.63 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 2.54 Mn |
| Sep 30, 2023 | 4.86 Mn |
| Jun 30, 2023 | 6.84 Mn |
| Dec 31, 2022 | 4.14 Mn |